Skip to content
Inbakicept
Inbakicept is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
29 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD0022891314
Urinary bladder neoplasmsD001749C67111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Squamous cell carcinoma of head and neckD000077195123
Hiv infectionsD015658EFO_0000764B20313
HivD006678O98.7313
NeoplasmsD009369C80323
Merkel cell carcinomaD015266EFO_1001471C4A22
Liver neoplasmsD008113EFO_1001513C22.0122
Triple negative breast neoplasmsD064726222
Colorectal neoplasmsD01517922
Acquired immunodeficiency syndromeD000163EFO_0000765B20212
Hepatocellular carcinomaD006528C22.0111
Show 16 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.111
Non-hodgkin lymphomaD008228C85.911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD01059911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameINBAKICEPT
INNinbakicept
Description
Inbakicept is a protein pharmaceutical. It is currently being investigated in clinical studies.
Classification
Protein
Drug classreceptor molecules or membrane ligands, natural, modified or modified
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4594318
ChEBI ID
PubChem CID
DrugBank
UNII IDQN4LI58PJ5 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details